Summary of Purpose
To evaluate the efficacy and safety of catheter-based thrombectomy for reperfusion by removing a thrombus in a cerebral blood vessel in patients with acute cerebral infarction (within 8 hours after onset), in whom intravenous administration of tissue plasminogen activator (t-PA) is not indicated or reperfusion cannot be achieved by intravenous t-PA administration.Read More →
The following dates are available for this trial. Trial information last updated on 11 November 2016.
|1 Oct 2016||9 Nov 2016||1 Dec 2017||Unavailable||1 Nov 2016||Unavailable|
|Start Date||First Received||1st Completion||Completion||Verification||Results|
- JIMRO Co., Ltd. Lead
- Hisao Hirayama